Lindberg, H., Svane, I. M., Hogdall, E. V., Nielsen, D. L., Theile, S., Spindler, N. J., . . . Eefsen, R. L. (2023). Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): A study protocol. BMJ Publishing Group.
Chicago Style (17th ed.) CitationLindberg, Henriette, et al. Randomised Phase II Trial of Stereotactic Body Radiotherapy in Combination with Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer (CheckPRO): A Study Protocol. BMJ Publishing Group, 2023.
ציטוט MLALindberg, Henriette, et al. Randomised Phase II Trial of Stereotactic Body Radiotherapy in Combination with Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer (CheckPRO): A Study Protocol. BMJ Publishing Group, 2023.